Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Board finds that the discontinuance of the 100 percent evaluation for prostate cancer residuals effective January 1, 2011 was proper as there is no evidence of active malignancy or recurrence after this date.

The deciding factor: There was no evidence of local recurrence or metastasis of the Veteran's prostate cancer after January 1, 2011, and the initial 100 percent rating for prostate cancer was properly discontinued under DC 7528.

Claimed conditions
Prostate Cancer
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
None in this decision
Decision date
September 16, 2015
Citation
1539661

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1539661.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.